# Complement Component 3c and Tumor Necrosis Factor-α in Patients With Human Papillomavirus-Induced Cutaneous Warts

> **NCT04399577** · PHASE2 · COMPLETED · sponsor: **Zagazig University** · enrollment: 39 (actual)

## Conditions studied

- Warts

## Interventions

- **BIOLOGICAL:** Candida antigen

## Key facts

- **NCT ID:** NCT04399577
- **Lead sponsor:** Zagazig University
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-07-01
- **Primary completion:** 2019-03-03
- **Final completion:** 2019-09-03
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2020-05-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04399577

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04399577, "Complement Component 3c and Tumor Necrosis Factor-α in Patients With Human Papillomavirus-Induced Cutaneous Warts". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04399577. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*